Summit Global Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
3,182
+277
+10% +$94.8K 0.06% 172
2026
Q1
$1.02M Sell
2,905
-553
-16% -$197K 0.06% 190
2025
Q4
$1.13M Sell
3,458
-1,369
-28% -$434K 0.07% 175
2025
Q3
$1.36M Sell
4,827
-199
-4% -$57.7K 0.08% 130
2025
Q2
$1.4M Buy
5,026
+147
+3% +$41.6K 0.08% 142
2025
Q1
$1.52M Sell
4,879
-9,278
-66% -$2.74M 0.11% 110
2024
Q4
$3.69M Buy
+14,157
New +$4.2M 0.23% 89
2023
Q1
Sell
-2,307
Closed -$606K 500
2022
Q4
$606K Buy
2,307
+134
+6% +$35.9K 0.05% 285
2022
Q3
$490K Sell
2,173
-14,731
-87% -$3.57M 0.05% 314
2022
Q2
$4.11M Buy
16,904
+8,839
+110% +$2.17M 0.36% 74
2022
Q1
$1.95M Buy
+8,065
New +$1.85M 0.14% 152

Other funds holding AMGN

Summit Global Investments's AMGN Position: Q2 2026 in Review

Summit Global Investments increased its Amgen (AMGN) stake by 9.5% in Q2 2026, buying an estimated $94.8K and bringing the position to 3,182 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #172.

Summit Global Investments first reported a position in AMGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $4.11M in Q2 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Summit Global Investments held 3,182 shares of Amgen worth $1.15M as of Q2 2026.
  • Summit Global Investments bought 277 Amgen shares in Q2 2026, an estimated $94.8K.
  • Amgen made up 0.06% of Summit Global Investments's portfolio in Q2 2026, its #172 holding.
  • Summit Global Investments first reported a position in Amgen in Q1 2022 and has held it in 11 quarters since.
  • Summit Global Investments's Amgen position peaked at $4.11M in Q2 2022.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.